Millipore is offering Luminex's Flexmap 3D system, a multiplexing instrument that allows scientists to simultaneously perform up to 500 tests on a single sample.
The Flexmap 3D system meets the needs of medium- and high-volume laboratories and its ability to conduct many tests at once can significantly enhance the efficiencies of life-sciences research and drug discovery.
Based on Luminex's flexible Xmap Technology, Flexmap 3D system fills an essential segment between the low multiplex marketplace and the high multiplex microarray market.
The robust system provides: enhanced throughput for scientists at medium and high-volume laboratories; significantly enhanced throughput; higher multiplexing, with up to 500 analytes per well; improved analytical performance; 96 or 384 well-plate format; enhanced dual pipetting, automation and LIS compatibility; streamlined calibration and performance-verification routines; and easy maintenance with a simple workflow.
The Flexmap 3D system can perform multiplexed genomic, transcriptomic and proteomic biomarker analysis on a single platform.
It is ideal for applications such as SNP genotyping and gene-expression analysis, which are vital in areas such as high-throughput pharmaceutical research.
By enabling research to proceed more efficiently, the system allows faster screening of novel targets and an overall improvement in laboratory management.
